Engineering Cas12a Genome Editors with Minimized Trans-Activity

Tech ID: 32640 / UC Case 2022-071-0

Patent Status

Patent Pending

Brief Description

The inventors engineered a set of LbCas12a mutants through rational design and directed evolution. The engineered mutants can function as efficient genome editors with minimized trans-activity.

Suggested uses

Suggested uses for the engineered LbCas12a mutants with minimized trans-activity include:

  • reduced off-target genome editing in eukaryote cells. 
  • development into other molecular tools for genome editing.

Advantages

Related Materials

Learn About UC TechAlerts - Save Searches and receive new technology matches

Inventors

  • Doudna, Jennifer A.

Other Information

Keywords

genome editing

Categorized As

Additional Technologies by these Inventors